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INTRODUCTION
When a large, unselected and statistically valid number of modern city dwellers
is tested by intracutaneous injection of tuberculin in the usual test dose of about
of a milligram of Old Tuberculin Koch (0.1 cm. of a dilution of 1: 5,000 OTK),
some will react and some will not. If such testing is done nowadays on large
groups distinguished by ages, the results are likely to be approximately as follows:
Between birth and 2 years (in infancy), almost all will fail to react.
Between 2 and 10 years, many fewer will react than not.
Between 10 and 20 years, reactors and non-reactors will be nearly equal in
number.
Between 20 and 40 years, there will be significantly more reactors than non-
reactors.
Between 40 years and extreme old age, the number of non-reactors will be
greater in proportion to reactors than in the 20—40 year group.
Without citing exact figures in the interest of brevity, these ratios, as a trend,
are nevertheless submitted to reflect the true situation in New York City at
least, and are graphically presented for emphasis in Chart I. The ratios corre-
spond to the actual figures found by Pascher and Sulzberger (1) in a study of
the age incidence of positive tuberculin reactions in the New York Skin and Can-
cer Unit Clinic. Reference may also be made to the bibliography of that article
for other studies that substantiate the trend.
Tuberculin testing can be refined by employing the serial dilution method as
practised by dermatologists since its introduction by J. Jadassohn. When low
concentrations of tuberculin are used, down to j- , mg., it will be found that
some of the positive reactors still react; and with greater concentrations, up to
several milligrams, some of the seeming non-reactors to mg. will be found to
begin to react at or 1 mg. But some others of the non-reactors, almost all in-
fants and quite a few adults, will not react to any reasonable concentration or
milligrammage of tuberculin. In other words, some persons are practically com-
pletely insensitive or anergic to tuberculin.
One must digress at this point to restate and clarify terminology with regard to re-
activity to tuberculin. Much of this matter is fully treated in Sulzberger's book on derma-
tologic allergy (2). We may review, however, by defining sensitivity to tuberculin as a
* From the New York Skin and Cancer Unit, Department of Dermatology and Syphi-
lology (Marion B. Sulzberger, M.D., Director), Post-Graduate Medical School of the
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specifically acquired alteration in the capacity to react to tuberculin (an allergic trans-
formation) that is designated as normergic when the sensitivity is to concentrations of
tuberculin of the order of 0.1 cc. of 1:5,000 OTK (th mg). Hyperergic and hypoergic
sensitivity denote sensitivity to lesser and greater amounts of OTK respectively.
Insensitivity to tuberculin is harder to define unequivocally because it is of several
varieties, each of which requires neat qualification in order to distinguish them. For ex-
ample, the person who has never been adequately exposed to the tubercie bacillus is in-
sensitive to tuberculin; some febrile states, cachexia and moribundancy abolish tuberculin
sensitivity or induce insensitivity for as long as they obtain; and finally, some workers,
we among them, believe that there may be a species of insensitivity to tuberculin that
results from infection with the tuberele bacillus and is therefore another specifically ac-
quired alteration in the capacity to react (an allergic transformation) comparable, in so
far as it is of allergic mechanism, to the more common acquired increased sensitivity.
The word anergy is literally comprehensive for all three (quite radically different) kinds of
insensitivity to tuberculin but needs adjectival modification in each case to distinguish
the quality of each. J. Jadassohn used "nonspecific, negative or absolute anergy" to delimit
the insensitivity of febrile states, cachexia and moribundancy; and "positive, specific or rela..
CHART I
Trend of tuberculin reactivity by age groups
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tive anergy' to indicate that insensitivity which is thought to be due to infection with tubercie
bacilli. To the best of our knowledge he did not employ a specifying term for the energy of
the preinfected state. We find that there is need for a precise designation of this phase too,
especially when it has to be considered in relation to all the other reactivities to tuberculin.
We propose, therefore, the phrase "original or native energy" for that lack of response which
is based upon absence of preceding, adequate sensitizing exposure. Chart II is a summary of
this terminology, which we shall use in the subsequent exposition.
The interpretation of a positive reaction to tuberculin either at a hyperergic
level or at a normergic level is generally agreed upon. Such persons have, or have
had, tuberculosis, or have been adequately exposed to tubercie bacilli, even if no
clinical event certifying such exposure is known.
The interpretation of absence of reaction to tuberculin in a healthy infant,
child or adolescent is also fairly well agreed upon. In young subjects, such lack
of reaction, or original, native allergy, usually means that such individuals do
not have, and have not had, tuberculosis, nor have they been adequately exposed
to the tubercie bacillus in an occult way.
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But the interpretation of an absent, or of an exceedingly hypoergic, reaction
to tuberculin, particularly one in middle or old age, is not so well agreed upon
and not so easily assumed to indicate absence of present or past, manifest or
occult, infection with tubercie bacilli. There is dispute whether relative anergy
or perhaps even utter insensitivity to tuberculin in mature adults may not be of
two varieties, namely: 1. An original or native anergy that is the same in meaning
as the circumstance at birth and early infancy, i.e., indicative of absence of pres-
ent or past adequate exposure to tubercie bacilli, and 2. a positive anergy which
is an acquired relative insensitivity to tuberculin in spite of, or precisely because
of, previous infection with, or adequate exposure to, tubercie bacilli. We omit
CHART II
Terminologic table relating to reactivities to tuberculin
Tuberculin Insensitive States CAner gies): These may or may not be allergic phenomena.
Native or Original Anergy: The insensitivity to tuberculin of the preinfected state;
the aboriginal negative reactivity of a host upon first contact with the tubercie bacillus
or its products.
Nonspecific (negative or absolute) Anergy: The insensitivity to tuberculin that results
from certain febrile and depleted states—measles, meningitis, cachexia and mori-
bundancy—because the skin loses its capacity to react in general to many agents
that it reacted to previously in the healthy state. Tuberculin-like responses to tn-
chophytin, oidiomycin, Frei antigen, etc. are likewise lost if they previously existed
and for the same reason, namely, the humoral, cellular or other exhaustion of the
skin under conditions of fever and other severe deprivation.
Positive, Relative or Specific Anergy: Hyposensitivity to tuberculin that is a specifically
acquired alteration in the capacity to react (an allergic transformation). It is not the
same in quality as native or original anergy, nor as negative, non-specific anergy.
Tuberculin Sensitive States: These are all allergic phenomena and are quantitatively dis-
tinguished as:
Normergy: The average specifically acquired capacity to react to tuberculin. It is elicited
by an amount of tuberculin of the order of -y mg.
Hyperergy: Reactivity in excess of normergy. It may be demonstrated by much less
than y mg. of OTK.
Hypoergy: Reactivity below levels of normergy. (This hypoergy may be, and often is,
a manifestation of positive anergy—see above.)
further discussion of nonspecific anergy from this point on because it is not rele-
vant to the rest of this study and exposition.
The main types of evidence adduced to prove J. Jadassohn's thesis that there
exists such a category of insensitivity to tuberculin as positive, specifically acquired
anergy are as follows:
First is the technically difficult and not universally accepted demonstration of relatively
high titres of anticutins, i.e., of specific antibodies that inhibit the skin reaction produced
by tuberculin. With the proper (very exacting) technic these substances maybe found with
considerable regularity in persons with so-called positive anergy; whereas tuberculin
sensitive persons possess preponderant procutins, i.e., substances which promote the skin
reaction produced by tuberculin.
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Second is the demonstration of relative tuberculin insensitivity in most cases of certain
cutaneous and systemic diseases, particularly sarcoidosis, in which the relative anergy
to tuberculin cannot uniformly be due to the absence of infection with, or of adequate
exposure to, the tubercle bacillus.
Third, some of the presumptive tuberculoderms are characterized by relative tuberculin
anergy, e.g., lupus miliaris disseminatus faciei, some cases of papulonecrotic tuberculids,
etc. Also, as is well known, the whole complex of sarcoidosis has many resemblances to the
other admitted forms of tuberculosis.
Finally, the oft considerable incidence of relative tuberculin anergy in an asymptomatic
older age group is hard to explain in our social milieu and in our time on the basis of absence
of adequate previous contact with the tubercle bacillus.
Another approach to the problem of determining whether or not there exists a
form of tuberculin anergy that is different in quality from the absence of tuber-
culin sensitivity in the pre- or uninfected (native or original anergy), was sug-
gested and pursued by Lemming (3). This worker injected BUG vaccine, of
rather high dose, in a patient with a form of sarcoidosis (uveo-parotid fever,
Heerfordt) and with utter tuberculin anergy. Several months later he found a
sarcoid placque at the site of the injection and no change in the tuberculin insen-
sitivity. Some time later Warfvinge (4) did the very same thing with living,
virulent human tubercle bacilli in a patient who was suffering concurrently from
both active pulmonary tuberculosis and systemic sarcoidosis. The patient's spu-
tum provided the microorganisms. Before the injection of the bacilli the tuber-
culin reaction in this patient was negative with as much as 3 mg. of tuberculin;
and that insensitivity was not influenced in any way by the procedure. A sarcoid
lesion was produced at the site of inoculation.
Both of these investigators concluded that the tuberculin anergy of sarcoidosis
was distinct in quality from that of the original state of absence of infection
since otherwise the production of tuberculin positivity should have resulted from
their inoculations with tubercle bacilli (BCG and virulent human bacilli).
EXPERIMENTAL
Following all of these lines of reasoning, we undertook to study the clinical
course of the local cutaneous and immunologic responses to BUG vaccinations in
both tuberculin positive and tuberculin negative subjects. Omitting the negative
anergy of cachexia and of certain acute or chronic overwhelming infections, etc.
(which is surely not a factor in our present test subjects) and assuming that
there are two different types of negative reactors, (i.e., 1) those never infected
and 2) those infected but in some manner attaining relative anergy) and that
there is essentially one type of positive reactor, we should expect three corre-
spondingly distinct courses of reaction to BCG vaccine.
In the clinical material available to us it was not feasible to vaccinate with
BCG newborns who are, doubtlessly, the best subjects for study of original or
native anergy (i.e., tuberculin insensitivity because of absence of previous ade-
quate exposure to the tubercle bacillus). We rather thought that since there al-
ready is a large experience with BCG vaccinations of infants, we would readily
find numerous accurate descriptions of the course of the local reaction. Here we
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ran into a curious difficulty. Upon search of the literature we were unable to find
a detailed description of what exactly happens in human beings at the site of
inoculation of BCG vaccine when given for the immunizing purpose by the intra-
cutaneous route. Such descriptions may exist in publications we have not located,
but from the fact that a great deal of BCG immunization was originally done
by oral administration and because dermatologists were not hitherto especially
concerned with this procedure, the minutely accurate description and time-table
of the cutaneous changes may have been neglected. In any event, the phenom-
enon does not have the publicity it deserves. We were able to find brief notes
about regional adenopathy, an ulcer some indefinite time after injection and
eventual healing by scar (5), but nowhere have we been able to find anything
comparable to the well-known descriptions of, say, the course of the cutaneous
lesions of smallpox vaccination. The order of skin changes and time sequences
of BCG vaccination are poorly recorded. Only the time of appearance of tuber-
culin positivity has been well observed and stated. In a large measure, the litera-
ture on BCG vaccination of recent years seems to consist of statistical studies
on the worth of the procedure as a preventive against tuberculosis.
However, direct and personal enquiry of reliable and experienced workers with
BCG vaccine, like Konrad Birkhaug of the New York State Department of
Health and Sol Roy Rosenthal of the Tice Laboratory in Chicago, yielded assur-
ance that the clinical course of the skin responses to BCG vaccine by intracuta-
neous injection in the uninfected human being imitates pretty well the response
to the same procedure in the guinea pig. Birkhaug (6) writes: ".. .When the non-
infected guinea pig (or man) is inoculated intradermally with a small dose of
virulent tubercie bacilli, the site of inoculation presents no visible lesion before
approximately two weeks when the overlying skin necrotizes and a persistent
ulcer is produced. When BCG or killed tubercie bacilli are used the same retarded
reaction occurs but the ensuing ulcer heals promptly. . ." Rosenthal (7) gives a
similar description by stating: ". . .In my experience the intradermal method
[of giving BCG—authors] follows stages of erythema, papulo-vesiculation and
ulceration to healing as you [authors] described. Usually the ulceration will occur
by the third to fourth week and complete healing by the first to third month. .
In other words, the clinical course of the skin response to intracutaneous injec-
tion of BCG vaccine in an uninfected human subject is a replica of the first part
of Koch's fundamental experiment (2). In brief, what happens is probably as fol-
lows: When BCG vaccine is given intracutaneously to a subject anergic to tuber-
culin because of no prior adequate exposure to tubercie bacilli (original or native
anergy), there ensues a period of about two weeks in which nothing much seems
to be happening clinically. This is the incubation period (2). Then there appear
seriatim: erythema, induration, papulation, vesiculation, pustulation, ulceration
and eventually healing by scar in some 6—9—12 weeks. Tuberculin positivity ap-
pears with or shortly after the expiration of the incubation period .
* Since going to press we have discovered a short but excellent note on the clinical and
immunologic course of BCG vaccination by the scratch method in the native or originally
anergic subject. This is by Prof. A. B. Marf an and is to be found in the foreword to reference
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And now, what would be the course of BCG vaccination in a tuberculin posi-
tive person? Again it is curious that the literature is deficient of a good descrip-
tion or even notation of this event, and this probably for the reasons suggested
before. However, we can quote Birkhaug (6) again: "...When a tuberculous
guinea pig (or a tuberculin positive person) is inoculated in the same manner,
already two days later an infiltration forms at the site of inoculation, the over-
lying skin becomes intensely inflamed, necrotizes, sloughs off and the process
heals rapidly. The accelerated reaction is dependent upon allergy [i.e., acquired
sensitivity to tuberculin-authors] and the severity of the ensuing necrotizing
process is directly proportional with tuberculin hypersensitiveness. . . . The local
reaction.. .is that classically associated with the Koch phenomenon.. . ."
Rosenthal's statement (7) on this point is only slightly different: ". . .A BCG
vaccination in tuberculin positive individuals does give a modified Koch's phe-
nomenon. There is no definite necrosis, but a pustule will appear in 48 hours
which will drain.. .
The clinical course of the skin response to BCG vaccination in a tuberculin
positive person is fortunately easy to study. We vaccinated with BCG five adults
who were normergic (i.e., reactive to 0.1 cc. of 1:5,000 or at most 1:10,000 OTK).
We found consistently that within a reaction time (2) of 24—48 hours (Fig. 1)
intense erythema appeared which proceeded rapidly into induration, papulo-
vesiculation, pustulation, ulceration and scar-healing in from 2—4 weeks (Fig. 2).
This is pretty exactly the second part of Koch's fundamental experiment (2).
Skin tests with tuberculin in the quantitative manner revealed that tuberculin
sensitivity remained substantially unchanged by this one inoculation. Whether or
not repetitions of the procedure would lead to any further immunologic change
was not tested in this series of experiments.
Finally, the crucial experiment: What is the course of BCG vaccination in a
tuberculin non-reactor who may be suspect of being allergic in spite of, or because
of, previous adequate exposure to, or infection with, tubercle bacilli? That is
(5). Below is a free rendering of this account into English with the literal French given in
a parenthesis. It is to be noted how exactly the phenomenon described is comparable in
every detail with what occurs in the guinea pig in the first part of Koch's fundamental
experiment.
"It is very interesting to watch the course of events which follows the vaccinating
scarifications. In subsequent days the scratches first vanish only to reappear, as a general
thing, within the third week. Then they become elevated, surrounded by erythema and
slightly scaly or crusted. The reaction keeps growing and reaches its peak at the end of
about a month. Then it subsides and slowly disappears in two or three months. The allergic
state often comes into being by the time the scratch marks become papular; it is almost
always established before the papules have completely involuted."
(II est très intéressant de suivre la marche des phénomènes qui suivent les scarifications
vaccinantes. Les jours qui suivent, les traits s'effacent d'abord et ne réapparaissent en
général quo dans le courant de la troisième semaine. Alors ils deviennent saillants, sont
bordés de rouge, légèrement squameux ou crofiteux. La reaction augmente et atteint son
acme au bout d'un mois environ. Puis dIe s'atténue et disparait lentement, après deux or
trois mois. L'allergie est souvent établie des quo les traits de scarification deviennent
papuleux; elle l'est presque toujours avant qu'ils aient disparu,)
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to say, what is the response to BCG inoculation of subjects with specifically ac-
quired relative anergy to tuberculin as is seen in cases of sarcoidosis for example?
As subjects for this experiment we studied four patients with sarcoidosis who
were insensitive to the intracutaneous injection of 0.1 cc. of 1: 100 or 1: 10 OTK
(1t1i or 1 mg). Inconsonance with the above stated hypothesis of several entirely
Fio. 1 FIG. 2
FIG. 1. 48-HouR-oLD REACTIONS TO BCG VACCINATIONS (Top: LIVE ORGANISMS; BOTTOM:
KILLED ORGANISMS) IN A TUBERCULIN POSITIVE PERSON (POSITIVE
TO 0.1 CC. OF 1:10,000 O.T.K.)
The reactions consist of erythema and induration of 2 cm. in diameter with a central
necrotizing papulo-pustule.
FIG. 2. THE BCG VACCINATIONS OF FIG. 1 AT 10 DAVS
The reactions are shallow, nearly healed ulcers
different forms of anergy, a third ctinieal course was observed in response to BCG
vaccination which differed on the one hand from what was found in normergic tuber-
culin sensitive persons and differed again from the described course in persons with
native or original anergy, (i.e., who are insensitive because of absence of previous
adequate exposure to the tubercle bacillus).
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In all our subjects with relative or specific anergy nothing much seemed to
happen for about 5—7 days and then a slowly growing papule began to appear
which tended to last indefinitely as a papule or a small placque (Figs. 3 and 4).
FIG. 3 FIG. 4
FIG. 3. The three distal reactions show the appearance of two-weelc old BCG vaccina-
tions and the Kveim test in a casc of sarcoidcsis with relative tuhcrculin anergy (negative
to 1:10 O.T.K.). The 13CC reactions consist of papules of nearly equal size and parallel
the clinical course of a Kveim test performed concurrently. All three papules remained
approximately as pictured for two months at which time they were excised for histologic
examination. Frei and oidiomycin antigens injected at the two proximal sites produced no
reactions.
FIG. 4. The appearance of well developed skin reaction to BCG vaccine (killed organ-
isms) in a case of lichcnoid sarcoid with a negative tuberculin reaction to 0.1 cc. of 1:100
O.T.K. Clinically the lesions look exactly like Boeck's sarcoid and much like the lesions
of the patient except that they are larger. The top reaction is 6 months' old and thc lower
is 4 months' old.
When developed to a plaque the reaction looked clinically like Boeck's sarcoid.
Neither the first nor the second part of Koch's experiment was reproduced in these
subjects with positive or relative specific anergy; and several repetitions of BCG vac-
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CHART III
Summary of experiments with BCG vaccinations
SUBJECT RACE DIAGNOSIS
CLINICAL COURSEREACTION TO TUBER- OF FIRSTCULIN BCG VACCINATION
CLINICAL COURSE
OF SUBSEQSwNT REMARKS
BCG VACCINATSONS
Subjects who were reactive to tuberculin
T). B. N Unresolved Pos. to 2d part Not done Illustrated io
1:10,000 OTK Koch's Figures 1 and
Fnnda- 2. Constitu-
mental tional effects,
Exp. fever and ma-
laise for 3
days. No so-
quelae
A. D. W Cranuloma Pos. to 2d part 2d part No constitu-
Annulare 1:5000 OTK Koch's Koch's tional effect
Funda- Fonda-
mental mental
Exp. Exp.
B. S. W Vitiligo Pos. to 2d part Not done No constitu-
1:5.000 OTK Koch's tional effect
Fund a-
montal
Exp.
H. C. W Urticaria Pos. to 2d part Not done 1\Ialaise for
1:10,000 OTK Koch's scveral (lays.
Fonda- No sequelae
mental
Exp.
D. K. W Dermato- Pos. to 2d part Not done No constitu-
phytosis 1:5,000 OTK Koch's tional effect
Funda-
mental
Exp.
Subjects who were relatively anergic to tuberculin
E. L. W Cutaneous Neg. to Sarcoid- Same on Illustrated in
sarcoid 1:100 OTK like pap- one repe- Figure 3. No
ule tition constitutional
effect. Lesion
excised at 2
months
V. B. N Cutaneous Neg. to Sarcoid- Same on No constitu-
sarcoid 1:10 OTK like pap- three tional effect
ule repeti-
tions
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CHART III—Coninued
CLINICAL COURSE CLINICAL COURSE
SUBJECT RACE EIAGXOSIS REACTION TO TUBER- OF FIRST OF SUBSEQUENT REMARKS
BCG VACCINATION BCG VACCINATLOAS
Subjects who were relatively anergic to tuberculin—Continued
J. J. N Cutaneous Neg. to Sarcoid- Same on Illustrated in
sarcoid 1:100 OTK like three Figure 4. No
plaques repeti- constitutional
tions effect. One
lesion excised
at six months,
one at four
months
A. B. N Cutaneous Neg. to Sarcoid- Same on No constitu.
and Os- 1:100 OTK like five repe- tional effects.
seous plaques titions Rapid involu-
sarcoid tion of both
cutaneous and
osseous sar-
coid processes
noted while
under testing
cination in them took substantially the same clinical course. Moreover quantitative
skin tests with serial dilutions of OTK showed that the tuberculin anergy persisted.
Chart III is a condensed tabulation of our experimental protocols.
The clinical and immunologic responses to BCG vaccinations in all of the
categories of tuberculin sensitivity (positive and negative varieties) together with
data from many sources are correlated in Chart IV.
The histopathology of the lesions produced by our experiments with BCG vac-
cination will be reported later.
ADDENDUM
In our first experiments, which are those cited and tabulated above, the BCG vaccina-
tions were preformed in selected normergic tuberculin-positive persons (not more reactive
than to 0.1 cc of 1:10,000 OTK nor less reactive than to 0.1 cc of 1:5,000) and only in such
cases of sarcoidosis as were markedly insensitive to tuberculin (not reactive to 0.1 cc of
1:100 OTK or 1:10). Subsequently we began to vaccinate cases with less selection as to
degree of tuberculin sensitivity, particularly cases in the hypoergic category.
We found what could be expected in the hyperergic, namely that the more exquisite the
tuberculin sensitivity, the more severe was the course of the human counterpart of the
Koch phenomenon. In some such cases, where the reactions to quantitative tuberculin
testing read, for example, plus-minus to 0.1 cc of 1:1,000,000 OTK, one plus to 1:100,000
and two to three plus to 1:10,000, BCC vaccination produced quite a large and rather
painful ulceration which lasted for several weeks. All cases nevertheless eventually healed
uneventfully by scar. Aside from the severe local reaction and sometimes some degree of
malaise in the extremely hyperergic, no serious sequelae were encountered. It is not recom-
mended, however, that this procedure be practised in cases of high tuberculin sensitivity,
unless with greatest caution and forethought.
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Further vaccinations of relatively hypoergic subjects produced some anomalous findings
which are not so easily fitted into the nice scheme of things which our first experiments
suggested. For example, one recent case of histologically confirmed cutaneous sarcoidosis
with tuberculin sensitivity of grade plus-minus to 0.1 cc of 1:5,000 OTK, one to two plus
to 1:1,000 and two plus to 1:100 gave the reaction of an ordinary tuberculin positive subject.
Another case, again histologically proven sarcoidosis with tuberculin reactivity of one
plus to 0.1 cc of 1:1,000 OTK and one to two plus to 1:100 similarly ran the course of the
second part of Koch's fundamental experiment. It may be remarked that both of these
reactions to BCG vaccine were milder in the size and duration of the ulcerous reaction
compared to those produced in cases exhibiting higher grades of tuberculin reactivity.
These cases conform essentially with our original finding that the course of BCG vaccina-
tion is determined by, follows and depends upon, the degree and quality of the tuberculin
reactivity that obtains in a particular case. What is denied by these cases is that the simple
diagnosis of sarcoidosis alone rules the delayed type of BCG response, an impression that
might mistakenly be gathered from the first trials. It appears rather that a case of sar-
coidosis must be attended by a relative insensitivity of properly low degree and quality
before that distinctive protracted course to the BCG vaccination occurs which is so different
from those other two responses that characterize the classical Koch phenomenon.
But we have come across one case which does not conform in several important respects
to the distinctive patterns of reaction described. This case must be detailed fully because
it is exceptional enough to seriously weaken our theses if the findings repeat thern$elves
in other cases and if the events cannot be explained in some other satisfactory fashion.
The subject was a boy of nine years who presented what appeared clinically as a hyper-
trophic scar on the chin. The history relevant to the cutaneous lesion was that a few months
before, he and playmates broke a discarded fluorescent bulb with the result that the patient
sustained a cut at the site of the presenting lesion by a glass fragment from the bulb. Histo-
logic examination revealed sarcoid structures and confirmed the expectation of what would
be found in a beryllium granuloma. The child's tuberculin reaction was negative to 0.1 cc
of 1:1000 OTK and plus-minus to 1:100. Thus he was apparently relatively anergic to tuber-
culin and since his cutaneous lesion was of near sarcoid histology, even if clearly due to
beryllium, it was of interest to see what his response would be to BCG vaccination. We
wanted to know whether he was still merely natively anergic to tuberculin or whether his
anergy was possibly of the positive variety and perhaps related in some way to the beryllium
effect. Upon BCG vaccination he responded within a reaction time of two days in the manner
of a tuberculin positive subject, i.e., with the second part of Koch's phenomenon. Con-
fronted with this unexpected finding, we considered the following rationalizing possi-
bilities:
1. The negative tuberculin reaction was false because the tuberculin used was faulty.
This we disproved by retesting the patient with freshly prepared dilutions of tuberculin
and by testing a known tuberculin positive person (one of us, M. L.) with the orginal batch
of graded dilutions. The patient reacted as before and the original preparation was found
to be active at least in the 1:10,000 strength.
2. The course of BCG vaccination is a better measure of a host's reactivity to the tubercle
bacillus than is the tuberculin reaction. In support of this possibility is a past history
in this patient—which we have been able to confirm by examination of a hospital record—of
a positive Mantoux test (1:1000) one year ago which prompted a special medical work-up
as a result of the finding. While that medical work-up was not conclusive of tuberculous
activity at the time, the item is pertinent. Also, one may recall certain other oddities of
the tuberculin reaction in general—inexplicable temporary reversals, zone phenomena,
etc .—but nothing of that sort can be proved in this case to convincingly explain away the
discrepancy between this negative tuberculin reaction and a BCG response that does not
correspond to either of those found in the two varieties of tuberculin negativity we have
described.
3. Beryllium poisoning may have a suppressing effect on tuberculin reactivity in a
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nonspecific fashion which may not extend to BCG vaccination which is performed with
whole, living microorganisms. This remains to be proved or disproved by future cases of
this kind.
Many another rationalization for this non-conforming case can be imagined, but one
must leave it to time, further search and study of such atypical reactions to provide the
answer.
DISCUSSION
We do not intend here to enter into debate on the cause of sarcoidosis nor to
discuss implications as to cause from the cutaneous and immunologic responses
to BCG vaccination here reported in cases of sarcoidosis We are of the opinion
that such debate, though it admittedly involves a great deal of tenuous spec-
ulation, may still be useful. We forego it mainly because there has been a tend-
ency in recent years for some of the debators and speculators to become pet-
ulant, querulous or acrimonious and to accuse each other of partisanship—as
though it profited anyone if the cause of sarcoidosis is, or is not, the tubercie
bacillus.
One may, however, pose the following questions for future and extended con-
sideration:
1. Is the distinctive response to BOG vaccination and the relative anergy to
tuberculin in sarcoidosis an expression of a characteristic immunebiologic state
that in certain peculiar circumstances results from exposure to, or infection with
the tubercie bacillus and does this peculiar immunebiologic state then give rise
to sarcoidosis as the result of the interaction with tubercie bacilli or their prod-
ucts?
2. Or, is that distinctive delayed response to BCG vaccination and that posi-
tive tuberculin anergy an expression of a characteristic immunebiologic state
that results from contact with tubercie bacilli but is unrelated to an incidental,
nontuberculous disease, namely, sarcoidosis?
3. Or, are those distinctive responses to tuberculin and to BOG vaccination
a modification of ordinary tuberculin sensitivity, a chronically distorted or modi-
fied reaction attributable to the action of a peculiar, coincidental, nontuberculous
disease, namely, sarcoidosis?
4. Or finally, does the peculiar disposition to acquire anergy to tuberculin and
to react in a distinctive fashion to BOG vaccination result from certain unknown
X-factors which also predispose to the acquisition of sarcoidosis? i.e., are the tu-
berculin anergy with its accompanying type of reaction to BOG vaccine and the
sarcoid disease both the results of an unknown disease mechanism but not
causally related to each other?
Possibility 1 would be disproved if a nontuberculous cause for sarcoidosis were
finally discovered, but this is not yet the case. At the present state of knowledge
we find it attractive to imagine that the person who reacts to tuberculin in the
manner of positive anergy is a candidate for sarcoidosis either of tuberculous
cause, or perhaps also from other infectious and non-living agents, and would
develop some part of the sarcoidosis complex if and when adequately reinoculated
or exposed.
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SUMMARY
1. The usual responses of modern city dwellers to quantitative dilutions of
Old Tuberculin Koch are reviewed.
2. Analysis of these responses to tuberculin suggests that there are the fol-
lowing different degrees and kinds of reaction or absence of reaction: three grades
of sensitivity—i) normergy; 2) hyperergy; 3) hypoergy and three types of abso-
lute or relative insensitivity or anergy—1) native or original anergy; 2) nonspe-
cific, negative or absolute anergy; and 3) positive, specifically acquired relative
allergy. Several of these types of response to tuberculin seem to differ from the
others in basic cause, in principal and in effect.
3. It is postulated a priori that the clinical courses of intracutaneous BOG
vaccinations in subjects individually exhibiting the different types of tuberculin
response must be different too.
4. It is gathered from the observations and reports of previous investigators
that the postulation of different responses to BCG vaccinations holds true for
native or originally allergic persons and for tuberculin sensitive persons (norm-
ergic and hyperergic).
5. The experiments herewith reported confirm this at least for the tuber-
culin sensitive person and further demonstrate a third type of response to
BOG vaccination in positive anergic persons. (Native or original anergic persons
and nonspecific allergic persons have not as yet been studied by us in this
regard.)
6. From the observations and reports of others, it is pretty certain that the
response of native or original anergic persons to BCG vaccination is in accord
with the first part of Koch's Fundamental Experiment in the guinea pig, i.e., there
is an incubation period of about two weeks during which there is induction of tuber-
culin sensitivity and consequent inception of a local lesion with a limited clinical
course of some 2—3 months.
7. The reaction of tuberculin positive persons to BOG vaccination is shown from
the reports of others and from our own experiments to be like the second part
of Koch's Fundamental Experiment, i.e., there is no longer an incubation period
but there is instead a reaction time of 24—48 hours after which the local lesion begins
promptly and runs an accelerated course to healing in 2—3 weeks.
8. The response to BGG vaccination of the hypoergic, relatively or positively
anergic person (cases of sarcoid in this study) is entirely different from either of
the above two distinct reactions. In these instances inoculation intracutaneously
with BOG vaccine results, after a delay of 5—7 days, in a rather torpid, slowly
growing papule which does not show a tendency to heal and persists, seemingly in-
definitely, as a papule or small placque. Olinically the indurated papule or placque
mimics the sarcoid lesions of the subject.
9. Several hypotheses relative to the nature of tuberculin anergy in sarcoidosis
are listed and a brief statement is made of the possible implications of the char-
acteristically different response to BOG vaccination of tuberculin anergic persons
with sarcoidosis.
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DISCUSSION
Dr. Theodore Cornbleet: When persons who react negatively to tuberculin are vacci-
nated with BCG, 90% of them change to positive in two weeks and almost all do so in a
month. Since sarcoidosis is said to rest often on a tuberculous basis even when the tuber-
culin reaction is negative, it is interesting to note what happens when BCG vaccine is
inoculated into subjects with the Besnier-Boeck-Schaumann disease. A reversal of the
tuberculin reaction to positivity would perhaps speak more in favor of a nontuberculous
cause of sarcoidosis. Contrariwise, persistence of a negative reaction under such circum-
stances would seem to point towards a special immune state present in this syndrome which
suppresses a reaction to tuberculin in the presence of infection with the Koch organism.
Doctor S. R. Rosenthal and I have observed a group of six subjects with sarcoidosis
who have been inoculated with BCG vaccine by the multiple puncture method. Five were
tuberculin negative and the sixth positive to 1:100 old tuberculin (1 milligram). Tuberculin
tests were repeated at monthly intervals. There was no change in the degree of reaction
to tuberculin after vaccination in the individual who was previously positive. One of the
group of five that was negative became positive at the sixth month following vaccination.
The four remaining of those who reacted negatively have continued to do so thus far.
An apparent therapeutic response should be noted here, too, though not emphasized
because of the small number of subjects observed. There has been a marked improvement
or apparently complete resolution of signs of the disease within three months following
the BCG vaccination.
Dr. E. Traugolt Bernstein: I think the introduction of BCG tests for reason of diagnosis
is of great importance. I saw a patient who had all the morphological attributes of sar-
coidosis and after performing a biopsy the histological picture showed typical "naked"-
epithelial tubercies. We performed the usual Mantoux tests and had a very strong positive
reaction in the dilution 1 :10,000. This is of course, a discrepancy, because in sarcoidosis
it is 50/50 proposition of sensitivity to tuberculin, and we thought of doing a Kveim test
and wait 2 months to evaluate the findings. We therefore substituted the BCG and found
a very strong reaction, with all the transitional symptoms occurring in 2—3 days. This was
very important because we found that sarcoidosis was actually an expression of syphilis,
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and the BCG test was important in evaluating the diagnosis from our standpoint. It proved
to be a syphilis patient, where the diagnosis had been mistaken. So that in this case the
BCG shortened the time needed to evaluate the real diagnosis and if we have such a stormy
reaction in a few days the Kveim test will be unnecessary and will soon be replaced by the
BCG test.
Closing Discussion by Dr. Sulzberger: Dr. Leider and I fully realize that this is just the
beginning, and everything is not settled in this vast field. It seems to us that what we
have shown is that through the use of tubercie bacillus—the modified, BCG bacillus,—
which has largely lost its virulence for man, the immunologic studies closely parallel, if
they are not identical with the original immunologic studies with vaccinia virus. If, as we
believe, the tubercle BCG bacillus is related to actual tuberculosis in a way similar to the
relation of cow-pox to smallpox, then it is not astonishing to find that in BCG inoculation
of the skin we duplicate the phenomenon of pox vaccination. In persons never infected
with tubercie bacilli, the first inoculation of BCG takes 6—7—8 days to develop and does not
have a very stormy course—just like the first vaccination. The reinoculation with BCG
takes a course somewhat like revaccination; first, as in sarcoid, or other diseases with posi-
tive tuberculin anergy, there is what corresponds to the "immune response", a very torpid,
non-acute, foreign body-type of reaction. Second, in persons with positive tuberculin tests,
one gets an accelerated response, with quick reaction and great inflammation and rapid
healing. A third point, it may be important in differential diagnosis. As far as I can tell,
true sarcoids, and other conditions with specific anergy to tuberculin generally, have a
characteristic peculiar form of response to BCG. Patients with anergy to tuberculin react
differently from other groups. Thus the few cases we examined of sarcoid proven due to
syphilis did not show the ordinary torpid sarcoid response to BCG, as found in idiopathic
sarcoidosis, but had an accelerated response. We hope to work further along these lines,
including leprous and other sarcoids.
